| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |